No products in the cart.
Product Description :
BD Glide with TBL Ultra-Fine Insulin Syringe 1ML U-40 31gx6mm Short Needle (Box of 100) is a single-use, sterile, non-toxic, plastic syringe. It comes with a latex-free rubber stopper with a flat plunger tip (no dead space) for correct insulin dosing.
The BD insulin syringe comes with U-40 graduated scale for 40 units or less. This 1ML U-40 Insulin Syringe 0.25mm (31G) X 6mm Needle from BD comes with TBL Technology for a smooth and comfortable injection experience. The Thin wall allows thinner needles with better drug flow, tri-Bevel tip allows easy penetration into the skin and micro bonded Lubrication allows smooth penetration. BD U‑40 insulin syringes have a red cover and scale marking denoting one unit each. Experience the shortest BD insulin syringe with BD Glide 6 mm needle.
BD syringes are intended for subcutaneous injection of U-40 Insulin. These syringes have only been tested and validated for the intended use. Once the syringe is prepared, the medication should be administered as soon as possible. Never re-shield the syringe after the injection. Use the syringe only once, destroy and put in a container for safe disposal.
• Brand : BD (Becton, Dickinson and Company)
• Ref #324902
• BD Glide with TBL Needle Technology
• Thin wall allows thinner needles with better drug flow
• Tri Bevel tip allows easy penetration into the skin
• Micro bonded Lubrication allows smooth penetration.
• U-40 1ML Syringe with 31G (0.25) X 6mm Needle
• Ultra-fine needle for minimal pain
• Smooth and comfortable injection experience.
• Have a red cover and scale marking denoting one unit each.
• For 40 units or less of insulin
• Shortest BD insulin syringe needle
• Clear markings to ensure precise dosage
• Experience the first 6mm needle from BD
• Sterilized using irradiation
• 100 numbers (10 packs of 10 numbers each) of Single Use 1ml Syringes
• Not made with natural rubber latex
• For Single Use Only
• Country of Origin : USA
Size | U-100, U-40 |
---|
Reviews
There are no reviews yet.